Disrupted O-GalNAc glycosylation as a mechanism and biomarker of SLC35A2-associated epilepsy
Mealer, R. G.; Anderson, J. J.; Smith, S. L.; Masters, B. M.; Barth, S. H.; Huizar, K. D.; Sran, S.; Yoon, H.; Ringland, A.; Muron, S. J.; Bowyer, M. E.; DGama, A. M.; Poduri, A. P.; Lidov, H. G.; Yang, E.; Furnari, J.; Canoll, P. D.; Ostendorf, A. P.; Koboldt, D. C.; Pierson, C. R.; Thomas, D. L.; Philpot, B. D.; Noel, M.; Cummings, R. D.; Heinzen, E. L.; Bedrosian, T. A.
Show abstract
Rare germline and somatic variants in SLC35A2 cause a spectrum of severe glycosylation disorders that commonly present with epilepsy. SLC35A2 encodes the Golgi transporter for UDP-galactose, but how its deficiency leads to severe neurodevelopmental disorders is unknown. Using a mouse model deficient for Slc35a2 in the forebrain, we identified a specific defect in O-GalNAc glycan synthesis, while other galactose-containing glycoconjugates remained intact. O-GalNAc glycans were absent from their normal location within neuronal tracts of the corpus callosum, and truncated precursors accumulated in the cortex on critical extracellular matrix molecules. Cultured primary neurons lacking Slc35a2 showed impaired development, hyperexcitability, and impaired O-GalNAc glycosylation. Finally, human brain tissue from cases of SLC35A2-associated intractable epilepsy displayed a strong correlation between variant burden and truncated O-GalNAc glycans. These findings provide a mechanistic link between genetic causes of SLC35A2-associated epilepsy and protein O-glycosylation that can be targeted for biomarker and therapeutic development.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cell type-specific biotin labeling in vivo resolves regional neuronal proteomic differences in mouse brain 96%
- Antibody-directed extracellular proximity biotinylation reveals Contactin-1 regulates axo-axonic innervation of axon initial segments. 96%
- Age-dependent regulation of axoglial interactions and behavior by oligodendrocyte AnkyrinG 95%
Similar papers in this journal
Similar papers in this journal
- Dynamic proteomic and phosphoproteomic atlas of corticostriatal axon neurodevelopment 94%
- Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice. 94%
- Cellular taxonomy and spatial organization of the ventral posterior hypothalamus reveals neuroanatomical parcellation of the mammillary bodies 94%
Similar papers in this journal
- Sex-specific single cell-level transcriptomic signatures of Rett syndrome disease progression 94%
- GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton 94%
- Partial inhibition of mitochondrial complex I attenuates neurodegeneration and restores energy homeostasis and synaptic function in a symptomatic Alzheimers mouse model 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.